BALCX
Price
$36.55
Change
-$0.03 (-0.08%)
Updated
Jul 18 closing price
Net Assets
252.37B
FIQAX
Price
$16.74
Change
-$0.00 (-0.00%)
Updated
Jul 18 closing price
Net Assets
4.44B
Interact to see
Advertisement

BALCX vs FIQAX

Header iconBALCX vs FIQAX Comparison
Open Charts BALCX vs FIQAXBanner chart's image
American Funds American Balanced C
Price$36.55
Change-$0.03 (-0.08%)
VolumeN/A
Net Assets252.37B
Fidelity Advisor Asset Manager 60% Z
Price$16.74
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets4.44B
BALCX vs FIQAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. FIQAX commentary
Jul 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Hold and FIQAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 252B vs. FIQAX (4.44B). FIQAX pays higher dividends than BALCX: FIQAX (2.05) vs BALCX (1.19). BALCX was incepted earlier than FIQAX: BALCX (24 years) vs FIQAX (7 years). BALCX (1.31) is less costly to investors than FIQAX (0.57). BALCX is a more actively managed with annual turnover of: 44.00 vs. FIQAX (17.00). FIQAX has a lower initial minimum investment than BALCX: FIQAX (0) vs BALCX (250). FIQAX annual gain was more profitable for investors over the last year : 8.20 vs. BALCX (6.23). FIQAX return over 5 years is better than : 37.61 vs. BALCX (34.75).
BALCXFIQAXBALCX / FIQAX
Total Expense Ratio1.310.57230%
Annual Report Gross Expense Ratio1.310.57230%
Fund Existence24 years7 years-
Gain YTD7.7148.20994%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets252B4.44B5,676%
Annual Yield % from dividends1.192.0558%
Returns for 1 year6.238.2076%
Returns for 3 years33.4832.55103%
Returns for 5 years34.7537.6192%
Returns for 10 years55.47N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTM1.400.07
+5.26%
Castellum
REPX26.551.30
+5.15%
Riley Exploration Permian
WLK83.432.18
+2.68%
Westlake Corp
FHI47.060.57
+1.23%
Federated Hermes
LYRA8.53N/A
N/A
Lyra Therapeutics Inc